Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-14
DOI
10.3389/fimmu.2019.02562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
- (2019) Dai Chihara et al. ANNALS OF HEMATOLOGY
- A Delicate Balance - The BCL-2 Family and its Role in Apoptosis, Oncogenesis, and Cancer Therapeutics
- (2019) Tristan Knight et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the Bcl-2 Family in B Cell Lymphoma
- (2019) Clare M. Adams et al. Frontiers in Oncology
- Global patterns and trends in the incidence of non-Hodgkin lymphoma
- (2019) Adalberto Miranda-Filho et al. CANCER CAUSES & CONTROL
- Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma
- (2019) Matthew J. Barth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model
- (2019) Kentaro Miyake et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
- (2018) Thais Bascuas et al. Frontiers in Immunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Attenuated Salmonella Typhimurium Carrying TRAIL and VP3 Genes Inhibits the Growth of Gastric Cancer Cells in Vitro and in Vivo
- (2018) Hong-Dan Cao et al. TUMORI
- SopB activates the Akt-YAP pathway to promote Salmonella survival within B cells
- (2018) Abraham García-Gil et al. Virulence
- Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
- (2018) Marco Antonio Hernández-Luna et al. Journal of Immunology Research
- BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
- (2018) Delphine Merino et al. CANCER CELL
- Non-Hodgkin lymphoma
- (2017) James O Armitage et al. LANCET
- The SWISS-MODEL Repository—new features and functionality
- (2016) Stefan Bienert et al. NUCLEIC ACIDS RESEARCH
- Engineering Salmonella as intracellular factory for effective killing of tumour cells
- (2016) Eva María Camacho et al. Scientific Reports
- ProQ3: Improved model quality assessments using Rosetta energy terms
- (2016) Karolis Uziela et al. Scientific Reports
- CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field
- (2015) Jumin Lee et al. Journal of Chemical Theory and Computation
- Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
- (2015) Jung-Eun Kim et al. Theranostics
- Salmonella induce autophagy in melanoma by the downregulation of AKT/mTOR pathway
- (2014) C-H Lee et al. GENE THERAPY
- Salmonella entericaserovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect
- (2014) Sofía Grille et al. IMMUNOLOGY
- Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium
- (2014) Jae-Ho Jeong et al. PLoS One
- Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas
- (2013) P. E. Massa et al. BLOOD
- Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis
- (2013) Peter E. Czabotar et al. CELL
- Therapeutic Effects of Salmonella Typhi in a Mouse Model of T-Cell Lymphoma
- (2013) Alejandrina Vendrell et al. JOURNAL OF IMMUNOTHERAPY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo
- (2012) Ikuhiko Nakase et al. JOURNAL OF CONTROLLED RELEASE
- Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL
- (2012) Marco A. Hernandez-Luna et al. LEUKEMIA & LYMPHOMA
- HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation
- (2012) Guillermina J Baay-Guzman et al. RESPIRATORY RESEARCH
- Bax: Addressed to kill
- (2011) Thibaud T. Renault et al. BIOCHIMIE
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular biology of Bax and Bak activation and action
- (2010) Dana Westphal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing
- (2010) Yoram Barak et al. BMC CANCER
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma
- (2010) J. J. Hwang et al. CLINICAL CANCER RESEARCH
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- QMEAN server for protein model quality estimation
- (2009) Pascal Benkert et al. NUCLEIC ACIDS RESEARCH
- IL-18-producing Salmonella inhibit tumor growth
- (2008) M Loeffler et al. CANCER GENE THERAPY
- Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
- (2008) Markus Loeffler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Attenuated Salmonella typhimurium with IL-2 Gene Reduces Pulmonary Metastases in Murine Osteosarcoma
- (2008) Brent S. Sorenson et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Intra‐tumoralSalmonella typhimuriuminduces a systemic anti‐tumor immune response that is directed by low‐dose radiation to treat distal disease
- (2008) Francesca Avogadri et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CHARMM-GUI: A web-based graphical user interface for CHARMM
- (2008) Sunhwan Jo et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma
- (2008) Brent S. Sorenson et al. JOURNAL OF PEDIATRIC SURGERY
- Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand
- (2008) Markus Loeffler et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started